𝔖 Bobbio Scriptorium
✦   LIBER   ✦

5-aminosalicylates in inflammatory bowel disease and chronic renal failure

✍ Scribed by F. Tekin; O. Ozutemiz; T. Ilter

Book ID
108604191
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
37 KB
Volume
22
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

5-Aminosalicylates and renal function in
5-Aminosalicylates and renal function in inflammatory bowel disease: A systematic review
✍ Javier P. Gisbert; Yago GonzΓ‘lez-Lama; JosΓ© MatΓ© πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 114 KB πŸ‘ 2 views

Nephrotoxicity has been described in some patients with inflammatory bowel disease (IBD) treated with 5-aminosalicylic acid (5-ASA). Studies with 5-ASA treatment in which serum creatinine or creatinine clearance was measured regularly show that nephrotoxicity is exceptional (mean rate of only 0.26%

5-Aminosalicylic acid therapy and the ri
5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease
✍ Jonathan P. Terdiman; Michael Steinbuch; William A. Blumentals; Thomas A. Ullman πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 2 views

## Background: Patients with inflammatory bowel disease (ibd) affecting the colon are at increased risk of developing colorectal cancer (crc). published data are conflicting about whether 5-aminosalicylic acid (5-asa) has chemopreventive properties against ibd-related carcinogenesis. the objective